Red Cross
Haemonetics loses $25M Red Cross deal, shares slide
Haemonetics (NYSE:HAE) said the American Red Cross went with 1 of its rivals for some components of the whole blood collection kits the relief agency uses, meaning a $25 million hit to Haemonetics’ top line.
Red Cross, biotech firm sue Johnson & Johnson over bandage sealant patents
Are hospitals overpaying for implantable medical devices? | MassDevice.com On Call
MASSDEVICE ON CALL — Some hospitals paid thousands more than others for the same implantable medical devices, costs that might be passed on to federal Medicare programs, according to a new government report.
A lack of transparency in pricing may be preventing health care providers from making the best decisions regarding the technologies they purchase, sometimes amounting to thousands of dollars in differences paid for the same device, according to the report, published by the U.S. Government Accountability Office.